UnknownPhase 2NCT03103555

Treatment of Adult-Onset Immunodeficiency With Bortezomib

Studying Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Mahidol University
Principal Investigator: Nasikarn Angkasekwinai, MD.
Faculty of Mdicine Siriraj Hospital, Mahidol University
Intervention: Bortezomib(drug)
Enrollment: 5 enrolled
Eligibility: 21-60 years · All sexes
Timeline: 2017 – 2019

Study locations (1)

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Bangkok, Thailand

Collaborators

Ministry of Health, Thailand

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03103555 on ClinicalTrials.gov

← Back to all trials